Literature DB >> 3969334

Progressive diaphyseal dysplasia: evaluation of corticosteroid therapy.

Y Naveh, U Alon, J K Kaftori, M Berant.   

Abstract

Progressive diaphyseal dysplasia is characterized clinically by crippling leg pain, fatigue, headache, poor appetite, muscle weakness, and waddling gait. Twelve affected patients, aged 2 years 4 months to 40 years, were treated with intermittent courses of low doses of prednisone given in a single dose on alternate mornings for periods ranging from 6 months to 10 years. The average initial dose of prednisone was 0.6 mg/kg/d, and average maintenance dose was 0.3 mg/kg/d. Relief of all crippling symptoms was achieved in all patients. No untoward serious side effects have been observed, and the growth of children was not slowed. However, corticosteroid therapy should be restricted to patients suffering from crippling pain. The mechanism through which steroids act remains undefined.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3969334

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  11 in total

1.  Orthopaedic. Radiology. Pathology Conference: Bilateral leg pain in a 4-year-old girl.

Authors:  Aaron Babb; Walter O Carlson
Journal:  Clin Orthop Relat Res       Date:  2008-06-20       Impact factor: 4.176

2.  Papilloedema, a complication of progressive diaphyseal dysplasia: a series of three case reports.

Authors:  M Wright; N R Miller; R M McFadzean; P Riordan-Eva; A G Lee; M D Sanders; G G McIlwaine
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

Review 3.  TGF-β Family Signaling in Connective Tissue and Skeletal Diseases.

Authors:  Elena Gallo MacFarlane; Julia Haupt; Harry C Dietz; Eileen M Shore
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-11-01       Impact factor: 10.005

4.  Progressive diaphyseal dysplasia and a low muscle carnitine.

Authors:  A M Bye; E Hodson; G Kewley; K Kozlowski
Journal:  Pediatr Radiol       Date:  1988

5.  Successful treatment with corticosteroid in a patient with progressive diaphyseal dysplasia.

Authors:  K Bourantas; S Tsiara; A A Drosos
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

6.  Progressive diaphyseal dysplasia masquerading as shoulder capsulitis in an adult.

Authors:  D Schapira; D Militeanu; O Israel; I Misselevich; Y Scharf
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

7.  Significant Improvement of Clinical Symptoms, Bone Lesions, and Bone Turnover after Long-Term Zoledronic Acid Treatment in Patients with a Severe Form of Camurati-Engelmann Disease.

Authors:  Giampiero I Baroncelli; Elena Ferretti; Cecilia M Pini; Benedetta Toschi; Rita Consolini; Silvano Bertelloni
Journal:  Mol Syndromol       Date:  2017-09-09

Review 8.  Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment.

Authors:  K Janssens; F Vanhoenacker; M Bonduelle; L Verbruggen; L Van Maldergem; S Ralston; N Guañabens; N Migone; S Wientroub; M T Divizia; C Bergmann; C Bennett; S Simsek; S Melançon; T Cundy; W Van Hul
Journal:  J Med Genet       Date:  2005-05-13       Impact factor: 6.318

Review 9.  Improvement of Bone Health and Initiation of Puberty Development in Camurati-Engelmann Disease With Glucocorticoid and Losartan Treatment: A Case Report and Review of Literature.

Authors:  Lijia Cui; Qian Li; Wenmin Guan; Wei Yu; Xiang Li; Weibo Xia; Yan Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-17       Impact factor: 6.055

10.  Camurati-Engelmann disease: unique variant featuring a novel mutation in TGFβ1 encoding transforming growth factor beta 1 and a missense change in TNFSF11 encoding RANK ligand.

Authors:  Michael P Whyte; William G Totty; Deborah V Novack; Xiafang Zhang; Deborah Wenkert; Steven Mumm
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.